Приказ основних података о документу

dc.creatorĐoković, Nemanja
dc.creatorNikolić, Katarina
dc.creatorLahtela‐Kakkonen, Maija
dc.creatorAgbaba, Danica
dc.date.accessioned2023-07-06T09:19:15Z
dc.date.available2023-07-06T09:19:15Z
dc.date.issued2018
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/4893
dc.description.abstractSirtuins are highly conserved class of NAD+-dependent lysine deacetylases. Altered function of sirtuin 2 (Sirt2) is related to pathogenesis of cancer, inflammation and neurodegeneration, which makes Sirt2 very attractive drug target in novel epigenetic research [1]. A number of Sirt2 inhibitors have been recently developed, but for most of them are missing structural information of their interaction with the enzyme [2, 3]. Our molecular dynamic (MD) study was performed on recently resolved crystal structures of selective ligand-Sirt2 complexes [1]. In the MD study were defined significant interactions with novel inhibitors, one of key residues responsible for conformational stability of cofactor-binding pocket, and residue acting as gate-keeper for cofactor-binding loop. Some residues completely changed orientation after the MD simulation, compared to the starting crystal structures. This result indicates on the errors in the X-ray structures that may have influence on structure-based design of novel inhibitors. After clustering of MD trajectory, 20 conformations (centroids) from 20 clusters of Sirt2 have been selected as representative conformations for retrospective structure based virtual screening. The virtual screening performances were significantly improved by use of the ensemble of conformations, selected with this MD methodology, compared to screening against available X-ray structures.sr
dc.language.isoensr
dc.publisherSection for Medicinal Chemistry of the Slovenian Pharmaceutical Societysr
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/172033/RS//sr
dc.rightsopenAccesssr
dc.sourceEFMC-ISMC, XXV EFMC International Symposium on Medicinal Chemistry, Book of Abstractsr
dc.titleCombined molecular dynamics and virtual screening studies to identify novel sirtuin 2 inhibitorssr
dc.typeconferenceObjectsr
dc.rights.licenseARRsr
dc.citation.spage305
dc.citation.epage305
dc.description.otherXXV EFMC International Symposium on Medicinal Chemistry, Ljubljana, Slovenia, September 2-6, 2018
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs/bitstream/id/13396/Combined_molecular_dynamics_pub_2018.pdf
dc.identifier.rcubhttps://hdl.handle.net/21.15107/rcub_farfar_4893
dc.type.versionpublishedVersionsr


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу